Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
~ Achieved First Quarter 2024 Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently..
~ Achieved First Quarter 2024 Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently..
*MindBio scientist’s sleep research published in prestigious peer reviewed scientific journal*
*MindBio’s..
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Cutaneous Squamous Cell Carcinoma (Cscc) - Global Clinical Trials Review, 2024"..